ClearStar,Inc. Accelerated Growth in MIS and Notice of Results (3228I)
08 August 2019 - 4:02PM
UK Regulatory
TIDMCLSU TIDMTTM
RNS Number : 3228I
ClearStar,Inc.
08 August 2019
8 August 2019
ClearStar, Inc.
("ClearStar" or the "Company")
ClearStar drives accelerated growth in Medical Information
Services
Milestone achieved with over $1 million monthly sales in
July
Notice of Interim Results
ClearStar (AIM: CLSU), a provider of Human Capital IntegritySM
technology-based services specialising in background and medical
screening, is pleased to announce that it has achieved a key
milestone in its Medical Information Services ("MIS") with monthly
sales exceeding $1 million for the first time as the Company
accelerates growth in this business area.
MIS sales in July 2019 of $1.06 million represents 37% growth
over July 2018, and accounted for 47% of total revenues in the
month (July 2018: 45%). For the year to 31 July 2019, MIS revenue
was 27% ahead of the same period in 2018.
This growth is being driven by demand for ClearStar's
technologically differentiated mobile solution, ClearID, which
offers a streamlined test ordering process and allows integration
with the customer's human capital management systems to maximise
workflow efficiency. The Company also recently enhanced its MIS
offering with the introduction, in Q2 2019, of new services for
ordering breath alcohol screening to meet both Department of
Transportation (DOT) and non-DOT requirements, including a combined
drug and breath alcohol screening offer with consolidated test
location and results reporting.
Robert Vale, CEO of ClearStar, said: "We are proud to have
achieved this milestone of over $1 million in monthly revenue for
Medical Information Services. We are receiving ever-growing demand
as customers increasingly recognise the value that our solutions
can add to their screening programmes - to benefit both the
employer and the employee. We are also pleased to introduce our new
combined drug and breath alcohol testing service, which is the
first step towards our goal of providing complete medical review
services."
Notice of Interim Results
The Company gives notice that it will be announcing its interim
results for the six months ended 30 June 2019 on Wednesday 18
September 2019.
Enquiries:
ClearStar, Inc. +1 877 796 2559
Robert Vale, Chief Executive Officer
Jennifer Balleza, Chief Financial Officer
-----------------
finnCap Ltd. +44 20 7220 0500
-----------------
Jonny Franklin-Adams, Marc Milmo, Simon Hicks
- Corporate Finance
Andrew Burdis - ECM
-----------------
Luther Pendragon Ltd. +44 20 7618 9100
-----------------
Harry Chathli, Claire Norbury, Joe Quinlan
-----------------
About ClearStar
ClearStar, Inc. is a leading provider of Human Capital
IntegritySM technology-based services specialising in background
and medical screening. It provides employment intelligence direct
to employers and via channel partners/consumer reporting agencies
("CRAs") to support better recruitment and other decisions
affecting employees by increasing the quality, reliability and
visibility of information.
A seven-time Inc. 5000 honouree and founding member of the
National Association of Professional Background Screeners,
ClearStar has provided innovative technology solutions to
businesses in the human capital management industry from its
corporate offices in Alpharetta, Georgia since 1995. For more
information about ClearStar, please visit: www.clearstar.net.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORUBARRKAAWRUR
(END) Dow Jones Newswires
August 08, 2019 02:02 ET (06:02 GMT)
Clearstar (LSE:CLSU)
Historical Stock Chart
From May 2024 to Jun 2024
Clearstar (LSE:CLSU)
Historical Stock Chart
From Jun 2023 to Jun 2024